• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Initial high rate of misdiagnosis in Crimean Congo haemorrhagic fever patients in an endemic region of Turkey.

作者信息

Tasdelen Fisgin N, Doganci L, Tanyel E, Tulek N

机构信息

Ondokuz Mayis University (OMU) Faculty of Medicine, Department of Infectious Diseases, 55139, Samsun, Turkey.

出版信息

Epidemiol Infect. 2010 Jan;138(1):139-44. doi: 10.1017/S0950268809990318. Epub 2009 Jul 7.

DOI:10.1017/S0950268809990318
PMID:19580693
Abstract

Crimean Congo haemorrhagic fever (CCHF) has been an emerging tick-borne infection in some parts of Turkey since 2002, with a number of fatalities. Many of the initial non-specific symptoms of CCHF can mimic other common infections. Additionally, the seasonal pattern of the epidemic, and the waning attention of healthcare workers to the yearly index cases caused some delays in appropriate patient care and treatment. Between March 2004 and August 2008, 140 confirmed adult cases were evaluated retrospectively for initial diagnosis and treatment delays. This study clearly demonstrated that there are particular delays (4.8 days) in the referral system to initiate effective antiviral treatment in the tertiary-care centre which significantly affect fatality rates (P>0.05). A large number of patients (n=95, 68%) received an initial misdiagnosis of various infections other than CCHF. In conclusion, continuous medical education regarding CCHF in the epidemic area is essential in order to achieve a better survival rate from this deadly infection.

摘要

相似文献

1
Initial high rate of misdiagnosis in Crimean Congo haemorrhagic fever patients in an endemic region of Turkey.
Epidemiol Infect. 2010 Jan;138(1):139-44. doi: 10.1017/S0950268809990318. Epub 2009 Jul 7.
2
An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.土耳其安纳托利亚西部暴发克里米亚-刚果出血热疫情。
Int J Infect Dis. 2009 Nov;13(6):e431-6. doi: 10.1016/j.ijid.2009.02.011. Epub 2009 May 5.
3
Crimean-Congo haemorrhagic fever cases in Turkey.土耳其的克里米亚-刚果出血热病例。
Scand J Infect Dis. 2007;39(4):332-6. doi: 10.1080/00365540601053014.
4
The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007.2002 - 2007年土耳其克里米亚-刚果出血热的流行病学
Int J Infect Dis. 2009 May;13(3):380-6. doi: 10.1016/j.ijid.2008.07.021. Epub 2008 Nov 4.
5
[Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].[2008年土耳其克里米亚-刚果出血热病例实验室诊断中聚合酶链反应(PCR)和酶联免疫吸附测定-免疫球蛋白M(ELISA-IgM)结果的评估]
Mikrobiyol Bul. 2010 Jan;44(1):57-64.
6
Aetiology of PCR negative suspected Crimean-Congo hemorrhagic fever cases in an endemic area.流行地区聚合酶链反应阴性的疑似克里米亚-刚果出血热病例的病因
Pathog Glob Health. 2016 Jun-Jul;110(4-5):173-7. doi: 10.1080/20477724.2016.1213958.
7
Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.对初步诊断为克里米亚-刚果出血热的病例进行评估,并比较土耳其卡斯塔莫努一家二级护理医院收治患者的特征。
Afr Health Sci. 2014 Dec;14(4):873-81. doi: 10.4314/ahs.v14i4.15.
8
Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.土耳其一家三级护理医院中克里米亚-刚果出血热患者死亡的临床和实验室预测因素评估。
Scand J Infect Dis. 2010 Jul;42(6-7):516-21. doi: 10.3109/00365540903582418.
9
Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.口服利巴韦林治疗克里米亚-刚果出血热的疗效:来自土耳其的一项准实验研究。
J Infect. 2009 Mar;58(3):238-44. doi: 10.1016/j.jinf.2009.01.014. Epub 2009 Feb 26.
10
Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.克里米亚-刚果出血热病毒感染患者的危险因素分析:重新审视严重程度标准
Clin Microbiol Infect. 2006 Jun;12(6):551-4. doi: 10.1111/j.1469-0691.2006.01445.x.

引用本文的文献

1
Inflammation associated with monocyte/macrophage activation and recruitment corresponds with lethal outcome in a mouse model of Crimean-Congo haemorrhagic fever.与单核细胞/巨噬细胞活化和募集相关的炎症反应与克里米亚-刚果出血热小鼠模型中的致死结果相关。
Emerg Microbes Infect. 2024 Dec;13(1):2427782. doi: 10.1080/22221751.2024.2427782. Epub 2024 Nov 19.
2
Crimean-Congo hemorrhagic fever cases diagnosed during an outbreak of Sudan virus disease in Uganda, 2022-23.2022-2023 年乌干达苏丹病毒病疫情期间诊断的克里米亚-刚果出血热病例。
PLoS Negl Trop Dis. 2024 Oct 16;18(10):e0012595. doi: 10.1371/journal.pntd.0012595. eCollection 2024 Oct.
3
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus.
复制子颗粒疫苗接种诱导非中和性抗核蛋白抗体介导的克里米亚-刚果出血热病毒控制。
NPJ Vaccines. 2024 May 23;9(1):88. doi: 10.1038/s41541-024-00877-1.
4
Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Diagnosis, Clinical Management, and Therapeutics.克里米亚-刚果出血热病毒临床医师诊疗手册:诊断、临床管理和治疗。
Emerg Infect Dis. 2024 May;30(5):864-873. doi: 10.3201/eid3005.231648.
5
Distribution pattern of Crimean-Congo Hemorrhagic Fever in Asia and the Middle East.亚洲和中东地区克里米亚-刚果出血热的分布模式。
Front Public Health. 2023 Jan 26;11:1093817. doi: 10.3389/fpubh.2023.1093817. eCollection 2023.
6
Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.克里米亚-刚果出血热的诊断检测
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01580-19.
7
Aetiology of PCR negative suspected Crimean-Congo hemorrhagic fever cases in an endemic area.流行地区聚合酶链反应阴性的疑似克里米亚-刚果出血热病例的病因
Pathog Glob Health. 2016 Jun-Jul;110(4-5):173-7. doi: 10.1080/20477724.2016.1213958.
8
Severe Crimean-Congo haemorrhagic fever presented with massive retroperitoneal haemorrhage that recovered without antiviral treatment.严重的克里米亚-刚果出血热表现为大量腹膜后出血,未经抗病毒治疗即康复。
BMJ Case Rep. 2011 Aug 19;2011:bcr1020103408. doi: 10.1136/bcr.10.2010.3408.